Form4.ai tracks every SEC insider trade in real time. See every MIRM insider filing with a free account — no card.
See every MIRM insider filing — free account, no card.
Free accountMirum Pharmaceuticals, Inc. (MIRM) has 8 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $600K. Most recent filing: Oct. 19, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 19, 2026 SEC filing | Howe Jolanda SVP, GLOBAL CONTROLLER | Option exercise | $309,995 | — |
| Oct 6, 2026 SEC filing | Peetz Christopher CHIEF EXECUTIVE OFFICER | Option exercise | $211,179 | — |
| Sep 15, 2026 SEC filing | BJERKHOLT ERIC CHIEF FINANCIAL OFFICER | Vest & sell-to-cover | +8,390 sh | — |
Create a free account to see all 8 MIRM filings from the last 90 days. No card needed.
Create free accountWant MIRM insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.